ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Neoplasm Metastasis
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near Cincinnati, OH, USA:

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Active, not recruiting
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Cincinnati, Ohio, United States and 31 other locations

This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...

Enrolling
Estrogen-receptor-positive Breast Cancer
Breast Neoplasms
Drug: goserelin
Drug: (Z)-endoxifen

Phase 2

Atossa Therapeutics

Edgewood, Kentucky, United States and 14 other locations

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer...

Enrolling
Breast Cancer
Triple Negative Breast Cancer
Drug: Pembrolizumab
Drug: Sacituzumab Govitecan

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Cincinnati, Ohio, United States and 14 other locations

with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...

Enrolling
HER2-negative Breast Cancer
Drug: Doxorubicin
Drug: Cyclophosphamide

Phase 2

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Dayton, Ohio, United States of America and 42 other locations

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Cincinnati, Ohio, United States and 260 other locations

of tumor and/or stromal area of infiltrating lymphocytes prior to initiation of standard neoadjuvant chemotherapy. At enrollment, patients ...

Active, not recruiting
Stage IIIA Breast Cancer
Estrogen Receptor-positive Breast Cancer
Drug: Paclitaxel
Drug: Cyclophosphamide

Phase 2

Virginia Commonwealth University (VCU)
Virginia Commonwealth University (VCU)

Edgewood, Kentucky, United States and 3 other locations

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cincinnati, Ohio, United States and 163 other locations

ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...

Active, not recruiting
Breast Cancer
Drug: PF-07220060
Drug: letrozole

Phase 3

Pfizer
Pfizer

Cincinnati, Ohio, United States and 462 other locations

the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer...

Enrolling
Breast Cancer
ER Positive Breast Cancer
Drug: Palazestrant
Drug: Palazestrant matching-placebo

Phase 3

Olema Pharmaceuticals

Cincinnati, Ohio, United States and 123 other locations

endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...

Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen

Phase 3

Stemline Therapeutics
Stemline Therapeutics

Fairfield, Ohio, United States and 535 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems